Effects of sodium valproate on corticotropin-releasing factor systems in rat brain

Neuropsychopharmacology

Volumn 24, Issue 6, 2001, Pages 624-631

  Stout, Steven C ^a   Owens, Michael J ^a   Lindsey, Kimberly P ^a   Knight, David L ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Bipolar disorder; Corticotropin releasing factor (CRF); Mood stabilizer; Valproic acid

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE; VALPROATE SEMISODIUM;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; HORMONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; LONG TERM EXPOSURE; MALE; MANIC DEPRESSIVE PSYCHOSIS; MEDIAN EMINENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAPHE NUCLEUS; RAT;

ANIMALS; ANTICONVULSANTS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NEURONS; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER; SYNAPSES; VALPROIC ACID;

EID: 0035024284     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00243-8     Document Type: Article

References (35)

1. Alheid G.F., Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders. The striatopallidal, amygdaloid, and corticopetal components of substantia innominata Neuroscience. 27(1):1988;1-39.
2. Banki C.M., Karmacsi L., Bissette G., Nemeroff C.B. Cerebrospinal fluid neuropeptides in mood disorder and dementia. J Aff Disord. 25(1):1992;39-45.
3. Baram T.Z., Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Develop Brain Res. 61(1):1991;97-101.
4. Bellivier F., Leboyer M., Courtet P., Buresi C., Beaufils B., Samolyk D., Allilaire J.F., Feingold J., Mallet J., Malafosse A. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiat. 55(1):1998;33-37.
5. Berrettini W.H., Nurnberger J.I. Jr., Zerbe R.L., Gold P.W., Chrousos G.P., Tomai T. CSF neuropeptides in euthymic bipolar patients and controls. Br J Psychiat. 150:1987;208-212.
6. Eadie M.J., Hooper W.D., Dickinson R.G. Valproate-associated hepatotoxicity and its biochemical mechanisms. Med Toxicol Adverse Drug Exper. 3(2):1988;85-106.
7. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress Ann NY Acad Sci. 697:1993;53-60.
8. Heinemeyer G., Nau H., Hildebrandt A.G., Roots I. Oxidation and glucuronidation of valproic acid in male rats - Influence of phenobarbital, 3-methylcholanthrene, beta-naphthoflavone, and clofibrate. Biochem Pharmacol. 34(1):1985;133-139.
9. Heit S., Owens M.J., Plotsky P.M., Nemeroff C.B. Corticotropin-releasing factor, stress, and depression. Neuroscientist. 3:1997;186-194.
10. Imaki T., Vale W. Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus. Brain Res. 623(2):1993;223-228.
11. Imaki T., Wang X.-Q., Shibasaki T., Harada S., Chikada N., Takahashi C., Naruse M., Demura H. Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription, and CRF biosynthesis in the paraventricular nucleus (PVN). Molec Brain Res. 32:1995;261-270.
12. Jingami H., Matsukura S., Numa S., Imura H. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/β-lipotropin precursor mRNA in the pituitary in rats. Endocrinology. 117:1985;1314-1320.
13. Kalin N.H. Management of the depressive component of bipolar disorder. Depres Anxiety. 4:1997;190-198.
14. Keck P.E. Jr., McElroy S.L. Antiepileptic drugs. Schatzberg A.F., Nemeroff C.B. Textbook of Psychopharmacology. 1998;431-454 The American Psychiatric Press, Washington, DC.
15. Kovács K.J., Makara G.B. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion. Brain Res. 474:1988;205-210.
16. Ladd C.O., Owens M.J., Nemeroff C.B. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology. 137:1996;1212-1218.
17. Löscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res. 18:1993;485-502.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall P.J. Protein measurement with Folin phenol reagent. J Biol Chem. 193:1951;265-275.
19. Makino S., Gold P.W., Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res. 640:1994;105-112. a.
20. Makino S., Gold P.W., Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis. Comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus Brain Res. 657:1994;141-149. b.
21. McElroy S.L., Keck P.E., Pope H.G. Sodium valproate. Its use in primary psychiatric disorders J Clin Psychopharmacol. 7(1):1987;16-24.
22. Mesdjian E., Ciesielski L., Valli M., Bruguerolle B., Jadot G., Bouyard P., Mandel P. Sodium valproate. Kinetic profile and effects on GABA levels in various brain areas of the rat Prog Neuropsychopharmacol Biolog Psychiat. 6:1982;223-233.
23. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacolog Rev. 43(4):1991;425-473.
24. Owens M.J., Vargas M.A., Knight D.L., Nemeroff C.B. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain. Acute time course, chronic treatment and abrupt withdrawal J Pharmacol Experiment Therapeut. 258(1):1991;349-356.
25. Owens M.J., Mulchahey J.J., Stout S.C., Plotsky P.M. Molecular and neurobiological mechanisms in the treatment of psychiatric disorders. Tasman A., Kay J., Lieberman J.A. Psychiatry. 1997;210-257 PA, W.B. Saunders, Philadelphia.
26. Palkovits M., Young W.S. III, Kovacs K., Toth Z., Makara G.B. Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy. Neuroscience. 85(1):1998;135-147.
27. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed:1986;Academic Press, Orlando, FL.
28. Plotsky P.M., Owens M.J., Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis Psychiat Clin North Am. 21(2):1998;293-307.
29. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology. 18(6):1998;492-502.
30. Sachs G.S. Bipolar mood disorder. Practical strategies for acute and maintenance phase treatment J Clin Psychopharmacol. 16(Suppl 1):1996;32S-47S.
31. Simmons D.M., Arriza J.L., Swanson L.W. A complete protocol for in situ hybridization of messenger RNA in brain and other tissues with radiolabeled single-stranded RNA probes. J Histotechnol. 12(3):1989;169-181.
32. Skelton K.H., Nemeroff C.B., Knight D.L., Owens M.J. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J Neurosci. 20(3):2000;1240-1248.
33. Vincent J.B., Masellis M., Lawrence J., Choi V., Gurling H.M., Parikh S.V., Kennedy J.L. Genetic association analysis of serotonin system genes in bipolar affective disorder. Am J Psychiat. 156(1):1999;136-138.
34. Weiss S.R., Nierenberg J., Lewis R., Post R.M. Corticotropin-releasing hormone. Potentiation of cocaine-kindled seizures and lethality Epilepsia. 33(2):1992;248-254.
35. Young W.S. III, Mezey E., Siegel R.E. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett. 70:1986;198-203.